WO2015044206A1 - Variantes de protéases inhibitrices stabilisées - Google Patents

Variantes de protéases inhibitrices stabilisées Download PDF

Info

Publication number
WO2015044206A1
WO2015044206A1 PCT/EP2014/070377 EP2014070377W WO2015044206A1 WO 2015044206 A1 WO2015044206 A1 WO 2015044206A1 EP 2014070377 W EP2014070377 W EP 2014070377W WO 2015044206 A1 WO2015044206 A1 WO 2015044206A1
Authority
WO
WIPO (PCT)
Prior art keywords
protease
amino acid
seq
positions
group
Prior art date
Application number
PCT/EP2014/070377
Other languages
German (de)
English (en)
Inventor
Hendrik Hellmuth
Brian LAUFS
Ayhan AYDEMIR
Thomas Weber
Timothy O'connell
Felix Jakob
Ronny Ernesto MARTINEZ
Ulrich Schwaneberg
Siegfried Andreas BEZDEK
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP14772337.3A priority Critical patent/EP3049519A1/fr
Publication of WO2015044206A1 publication Critical patent/WO2015044206A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus

Definitions

  • the invention is in the field of enzyme technology. More particularly, the invention relates to proteases and their preparation whose amino acid sequence has been modified, in particular with regard to use in detergents and cleaners, all sufficiently similar proteases with a corresponding change and nucleic acids coding for them. The invention further relates to methods and uses of these proteases and agents containing them, in particular washing and cleaning agents.
  • proteases are among the most technically important enzymes of all. For detergents and cleaners, they are the longest established and contained in virtually all modern, powerful detergents and cleaners enzymes. They cause the degradation of protein-containing stains on the items to be cleaned. Of these, in turn, proteases of the subtilisin type (subtilases, subtilopeptidases, EC 3.4.21 .62) are particularly important, which are serine proteases due to the catalytically active amino acids. They act as nonspecific endopeptidases and hydrolyze any acid amide linkages that are internal to peptides or proteins. Their pH optimum is usually in the clearly alkaline range.
  • Subtilases Subtilisin-like Proteases
  • R. Siezen pages 75-95 in "Subtilisin enzymes", edited by R. Bott and C. Betzel, New York, 1996.
  • Subtilases are naturally occurring formed by microorganisms. Of these, in particular, the subtilisins formed and secreted by Bacillus species are to be mentioned as the most important group within the subtilases.
  • proteases preferably used in detergents and cleaners from
  • Subtilisin type are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, in particular from Bacillus lentus DSM 5483,
  • Proteases are selectively or randomly modified by methods known from the prior art and thus optimized, for example, for use in detergents and cleaners. These include point mutagenesis, deletion or insertion mutagenesis or fusion with other proteins or protein parts. Thus, correspondingly optimized variants are known for most proteases known from the prior art.
  • Protease variants may be altered in addition to other positions at positions 3, 4, 99 and 199 in the alkaline protease counting method of Bacillus lentus DSM 5483 and
  • At said positions have the amino acids 3T, 41, 99D, 99E or 1991.
  • enzymes are not indefinitely stable when stored in protease-containing liquid detergents because the proteolytic activity of the proteases leads to degradation of the enzymes. In this case, not only by the degradation of the protease different enzymes, such as amylases, lipases, etc. affected by the degradation, but also the proteases themselves.
  • the enzyme may also be linked to an otherwise inferior inhibitor, e.g. Benzylmalonic acid (BMA), to be adjusted.
  • BMA Benzylmalonic acid
  • such an adaptation means that the enzyme is mutated so as to better enhance the inhibitor, i. for example, with higher binding affinity.
  • the invention therefore in a first aspect is a protease comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO.1 over the entire length thereof, which at the positions 160 and 185 of SEQ ID NO. 1 having amino acid residues 160G and 185R and having at least one, preferably two, more preferably three, especially four, more preferably five, most preferably six amino acid substitutions selected from the group consisting of 39E, 74D, 253D, 3T, 41 and 1991 in each case based on the numbering according to SEQ ID NO.1.
  • Another object of the invention is a method for producing a protease comprising substituting the amino acids at least one, preferably 2, more preferably 3, especially four, more preferably five, most preferably six positions, the positions 39, 74 and 253 3, 4 and 199 in SEQ ID NO.1, in one
  • Starting protease having at least 70% sequence identity to that shown in SEQ ID NO. 1 at its positions corresponding to positions 160 and 185 in SEQ ID NO.1, having amino acid residues 160G and 185R such that the protease at the corresponding positions comprises amino acids 39E and / or 74D and / or 253D and / or 3T and / or 41 and / or 1991.
  • a protease within the meaning of the present patent application therefore comprises both the protease as such and a protease produced by a method according to the invention.
  • Versions of the protease therefore relate both to the protease as a substance and to the corresponding processes, in particular preparation processes of the protease.
  • proteases encoding the proteases according to the invention or protease-producing nucleic acids, proteases or nucleic acids containing non-human host cells and proteases according to the invention comprising agents, in particular detergents and cleaners, washing and cleaning processes, and proteases according to the invention Uses connected.
  • the present invention is based on the surprising finding of the inventors that an inventive change in the positions corresponding to the positions 39, 74, 253, 3, 4 or 199 of the alkaline protease from Bacillus lentus DSM 5483 according to SEQ ID NO.1, in a Proteases which have one to the in SEQ ID NO.
  • 1 amino acid sequence comprises at least 70% identical amino acid sequence and the inhibitory mutations has 160G and 185R, such that at the corresponding positions of the amino acids 39E, 74D and / or 253D are present, an improved surfactant stability of this modified protease in detergents and cleaners causes.
  • the inventors have found that stability to surfactants can be improved by introducing mutations besides the inhibitory mutations 160G and 185R at positions 3, 4 and / or 199, in particular substitutions 3T, 41 and / or 1991 , This is particularly surprising to the extent that this combination of mutations acts synergistically without adversely affecting BMA inhibitor performance
  • proteases of the invention have a particular stability in detergents or cleaners, in particular to surfactants but also to bleaching agents and / or to temperature influences, in particular to high temperatures, for example between 50 and 65 ° C, especially 60 ° C, and / or acidic or alkaline
  • a protease according to the invention has a proteolytic activity, that is, it is capable of hydrolysing peptide bonds of a polypeptide or protein, in particular in a washing or cleaning agent.
  • a protease of the invention is therefore an enzyme which catalyzes the hydrolysis of peptide bonds and thereby is capable of adding peptides or proteins columns.
  • a protease according to the invention is preferably a mature protease, ie the catalytically active molecule without signal and / or propeptide (s). Unless otherwise stated, the sequences given refer to each mature enzyme.
  • the protease comprises an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, of their total length.
  • the protease has one of the mutations 39E, 74D or 253D, more preferably a combination of two mutations, i.
  • 39E and 74D, 39E and 253D or 74D and 253D and most preferably all three mutations, i. 39E + 74D + 253D, up.
  • the corresponding protease has at least one, preferably two, more preferably three, in particular four, more preferably five, most preferably six amino acid substitutions selected from P39E, N74D, S253D, S3T, V4I and V199I based in each case on the numbering according to SEQ ID NO.1.
  • the protease has as inhibitor mutations, one of the 3T, 41 or 1991 mutations, more preferably a combination of two mutations, i. for example 3T and 41, 3T and 1991 or 41 and 1991, and on
  • the protease, 160G and 185R as inhibitor mutations has at least two amino acid substitutions, wherein at least one amino acid substitution is selected from the group consisting of 39E, 74D and 253D, and at least one further amino acid substitution is selected from the group consisting from 3T, 41 and 1991, positions in each case based on the numbering according to SEQ ID NO.1, on.
  • protease having 160G and 185R as inhibitor mutations one of the following two amino acid substitutions: 39E + 3T, 39E + 41, 39E + 1991, 74D + 3T, 74D + 41, 74D + 1991, 253D + 3T, 253D + 41, 253D + 1991, Further preferred is the protease which, in addition to 160G and 185R as inhibitor mutations, has one of the following three amino acid substitutions: 39E + 74D + 3T, 39E + 74D + 41, 39E + 74D + 1991, 74D + 253D + 3T, 74D + 253D + 41 , 74D + 253D + 1991, 39E + 253D + 3T, 39E + 253D + 41, 39E + 253D + 41, 39E + 253D + 1991, 39E + 253D + 41, 39E + 253D + 1991, 39E + 253D + 41, 39E + 253D + 1991, 39E + 253D +
  • protease which, in addition to 160G and 185R as inhibitor mutations, has one of the following four amino acid substitutions: 39E + 74D + 253D + 3T, 39E + 74D + 253D + 41, 39E + 74D + 253D + 1991, 39E + 253D + 3T + 41, 39E + 253D + 3T + 1991, 39E + 253D + 4T +1991, 74D + 253D + 3T + 41, 74D + 253D + 3T + 1991, 74D + 253D + 41 + 1991,
  • protease having 160G and 185R as inhibitor mutations, one of the following five amino acid substitutions: 39E + 74D + 253D + 3T + 41, 39E + 74D + 253D + 3T + 1991, 39E + 74D + 253D + 41 + 1991, 39E + 74D + 3T + 41 + 1991, 39E + 253D + 3T + 41 + 1991, 74D + 253D + 3T + 41 + 1991.
  • protease which, besides 160G and 185R as inhibitor mutations, has all of the following amino acid substitutions is preferred: 39E + 74D + 253D + 3T + 41 + 1991.
  • a protease comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO.1 over its entire length, which correspond to the amino acid residues at the positions corresponding to positions 160 and 185 of SEQ ID NO.1 160G and 185R, and having at least one, preferably two, more preferably three, especially four, more preferably five, most preferably six amino acid substitutions selected from the group consisting of P39E, N74D, S253D, S3T, V4I and V199I in each case based on the numbering according to SEQ ID NO.1.
  • protease which comprises besides 160G and 185R as inhibitor mutations at least one, two or three amino acid substitutions of P39E, N74D and S253D, and at least one, two or three further amino acid substitutions selected from the group consisting of S3T, V4I and V199I, positions relative to each
  • protease which, in addition to 160G and 185R as inhibitor mutations, has the amino acid substitutions P39E, N74D, S253D, S3T, V4I and V199I.
  • a protease in the context of the present invention, the feature that a protease has the indicated substitutions means that it contains all the corresponding amino acids at the corresponding positions, i. none of the indicated positions is otherwise mutated or deleted, for example by fragmentation of the protease.
  • proteases of this type which are preferred according to the invention are shown in SEQ ID NOs. 2-15.
  • the proteases according to the invention can be one of those given in SEQ ID NOs 1-15
  • Amino acid sequences include or consist of.
  • sequence comparison is based on the BLAST algorithm established and commonly used in the prior art (see, for example, Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ. (1990) "Basic local alignment search Biol. 215: 403-410; and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
  • Lipman (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs"; Nucleic Acids Res., 25, pp.3389-3402) and is in principle accomplished by similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences of each other be assigned. A tabular assignment of the respective positions is referred to as alignment.
  • Another algorithm available in the prior art is the FASTA algorithm. Sequence comparisons (alignments), in particular multiple sequence comparisons, are created with computer programs.
  • Identity and / or homology information can be made about whole polypeptides or genes or only over individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions. They can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless otherwise indicated, identity or homology information in the present application, however, refers to the total length of the particular nucleic acid or amino acid sequence indicated.
  • Amino acid position of a numerically designated position in SEQ ID NO. 1 therefore corresponds to the corresponding position being assigned to the numerically designated position in SEQ ID NO. 1 in an alignment as defined above.
  • proteases of the invention may have other amino acid changes, in particular amino acid substitutions, insertions or deletions.
  • Such proteases are, for example, by targeted genetic modification, i. by mutagenesis, further developed and optimized for specific applications or specific properties (for example, in terms of catalytic activity, stability, etc.).
  • Nucleic acids are introduced into recombination approaches and thus used to generate completely novel proteases or other polypeptides.
  • the goal is to introduce into the known molecules targeted mutations such as substitutions, insertions or deletions, for example, to improve the cleaning performance of enzymes of the invention.
  • targeted mutations such as substitutions, insertions or deletions, for example, to improve the cleaning performance of enzymes of the invention.
  • the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
  • the net charge of the enzymes can be changed in order to influence the substrate binding, in particular for use in detergents and cleaners.
  • the stability of the protease can be further increased by one or more corresponding mutations, thereby improving its purification performance.
  • amino acid exchanges the following convention is used: first, the naturally occurring amino acid in the form of the international one-letter code is called, then follows the associated sequence position and finally the inserted amino acid. If no amino acid is given before the sequence position (for example 3T), the
  • Another object of the invention is therefore a protease which is characterized in that it is obtainable from a protease as described above as the starting molecule by one or multiple conservative amino acid substitution, wherein the protease in the counting according to SEQ ID NO.
  • Figure 1 also depicts the amino acid substitutions of the invention at positions corresponding to positions 160 and 185 and at least one of 39, 74, 253 and 3, 4 and 199 in SEQ ID NO.1, as described above.
  • amino acid substitution means the replacement of one amino acid residue with another amino acid residue, which substitution does not result in a change in polarity or charge at the position of the exchanged amino acid, e.g., the replacement of a nonpolar amino acid residue with another nonpolar amino acid residue
  • the protease is characterized in that it is obtainable from a protease according to the invention as starting molecule by fragmentation, deletion,
  • Matched starting molecule wherein the mutated contained in the starting molecule Amino acid residues at the positions corresponding to positions 160 and 185 and at least one of 39, 74, 253 and 3, 4 and 199 in SEQ ID NO.1 are still present.
  • their proteolytic activity i. their proteolytic activity is at least equal to that of the parent enzyme, i. In a preferred embodiment, the proteolytic activity is at least 80, preferably at least 90% of the activity of the
  • the protease is characterized in that it is obtainable from a protease according to the invention as starting molecule by one or more amino acid substitutions in positions which correspond to the positions 3, 4, 36, 42, 47, 56, 61, 69, 87, 96, 101, 102, 104, 1 14, 1 18, 120, 130, 139, 141, 142, 154, 157, 188, 193, 199, 205, 21 1, 224, 229, 236, 237, 242, 243, 255 and 268 the protease from Bacillus lentus according to SEQ ID NO. 1 are assigned in an alignment, wherein the protease in the count according to SEQ ID NO.
  • the further amino acid positions are determined by an alignment of the amino acid sequence of a protease according to the invention with the amino acid sequence of the protease from Bacillus lentus, as described in SEQ ID NO. 1 is defined.
  • the assignment of the positions depends on the mature (mature) protein. This assignment is to be used in particular if the amino acid sequence of a protease according to the invention has a higher number of
  • Amino acid residues comprises as the protease from Bacillus lentus according to SEQ ID NO. 1.
  • the alteration positions in a protease according to the invention are those which are just assigned to these positions in an alignment.
  • Advantageous positions for sequence changes, in particular substitutions, of the protease from Bacillus lentus which are preferably transferred to homologous positions of the proteases according to the invention and which confer advantageous functional properties on the protease, are therefore the positions 36, 42, 47, 56, 61, 69, 87, 96, 101, 102, 104, 1 14, 1 18, 120, 130, 139, 141, 142, 154, 157, 188, 193, 205, 21 1, 224, 229, 236, 237, 242, 243 , 255 and 268, to be assigned in an alignment with SEQ ID NO. 1 and thus in the count according to SEQ ID NO. 1.
  • the following amino acid residues are present in the wild-type molecule of the protease from Bacillus lentus (SEQ ID NO.16) or also the protease according to SEQ ID NO.1: S36, N42, A47, T56, G61, T69, E87 , A96, A101, 1102, S104, N1 14, H1 18, A120, S130, S139, T141, S142, S154, S157, V193, G205, L21 1, A224, K229, S236, N237, N242, H243, N255 and T268.
  • Substances G61A, S154D, S154E and V193M are furthermore advantageous if the correspondingly homologous positions in a protease according to the invention are not already naturally taken up by one of these preferred amino acids.
  • the amino acid residue at the position corresponding to position 99 in SEQ ID NO.1 is E, i. 99E. This residue is preferably retained in all possible modifications described above.
  • Examples of such proteases are those with the in SEQ ID NOs. 1-15 indicated amino acid sequences.
  • Parameters ie, for example, also an increase in the M value, observed in a protease variant according to the invention, the amino acid exchange was achieved by the same introduced amino acid, it is to be seen here a confirmation of the correct assignment.
  • the protease is characterized in that its purification performance compared to that of a protease comprising an amino acid sequence which corresponds to that shown in SEQ ID NOs. 1-15 corresponding amino acid sequence, is not significantly reduced, ie, has at least 80% of the reference washing power.
  • Methods for the determination of protease activity are familiar to the expert in the field of enzyme technology and are routinely used by him. For example, such methods are disclosed in Tenside, Vol. 7 (1970), pp. 125-132.
  • the protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-Nitroanilide (AAPF).
  • the protease cleaves the substrate and releases pNA.
  • the release of pNA causes an increase in absorbance at 410 nm, the time course of which is a measure of enzymatic activity (see Del Mar et al., 1979).
  • the measurement is carried out at a temperature of 25 ° C, at pH 8.6, and a wavelength of 410 nm.
  • the measuring time is 5 min and the measuring interval 20s to 60s.
  • the protease activity is usually indicated in protease units (PE). Suitable protease activities are, for example, 2.25, 5 or 10 PE per ml wash liquor. However, the protease activity is not equal to zero.
  • the protein concentration can be determined by known methods, for example, the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method (AG Gornall, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766).
  • the determination of the active protein concentration in this regard can be carried out by titration of the active sites using a suitable irreversible inhibitor (for proteases, for example phenylmethylsulfonyl fluoride (PMSF)) and determination of the residual activity (see M. Bender et al., J. Am. Chem. Soc 24 (1966), pp. 5890-5913).
  • a suitable irreversible inhibitor for proteases, for example phenylmethylsulfonyl fluoride (PMSF)
  • a method according to the invention further comprises one or more of the following method steps:
  • protease comprising amino acid residues 160G and 185R at the positions corresponding to positions 160 and 185 of SEQ ID NO.1 and at least one, preferably two, more preferably three, in particular four, more preferably five, most preferably has six amino acid substitutions selected from the group consisting of 39E, 74D, 253D, 3T, 41 and 1991, each based on the
  • protease (b) altering the amino acid sequence by fragmentation, deletion, insertion or substitution mutagenesis such that the protease has an amino acid sequence of at least 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 265, or 266 contiguous amino acids matches the parent molecule, the protease comprising
  • Amino acid residues 160G and 185R at positions corresponding to positions 160 and 185 according to SEQ ID NO. 1, and at least one, preferably 2, more preferably 3, especially 4, more preferably 5, most preferably 6 amino acid substitutions selected from the group consisting of 39E, 74D, 253D, 3T, 41 and 1991, each based on the numbering according to SEQ ID NO.1;
  • Amino acid residues 160G and 185R at the positions corresponding to the positions 160 and 185 according to SEQ ID NO.1, as well as at least one, preferably 2, more preferably three, especially four, more preferably five, most preferably six amino acid substitutions are selected from the group consisting of 39E, 74D, 253D, 3T, 41 and 1991, each based on the numbering according to SEQ ID NO.1.
  • a method according to the invention comprises one or more of the following method steps:
  • protease in the count according to SEQ ID NO. 1 has amino acid residues 160G and 185R and at least one, preferably 2, more preferably three amino acid substitutions selected from 39E, 74D and S253D;
  • the protease has an amino acid sequence of at least 50, 60, 70, 80, 90, 100, 110, 120, 130, 140 , 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 265 or 266 contiguous amino acids with the parent molecule, wherein the amino acid residues contained in the starting molecule 160G and 185R and at least one, preferably 2 , more preferably three
  • the protease or the protease produced by a method according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80 %, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92, 5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5% , or 98.8% identical to one of the amino acid sequences indicated in SEQ ID NOs: 1-15 over their entire length.
  • the protease or the protease produced by a method according to the invention has the amino acid residues 160G and 185R, preferably also 99E, and at least one, preferably 2, more preferably 3, the substitutions 39E, 74D and 53D and / or, in preferred embodiments, at least one, preferably 2, more preferably 3, substitutions 3T, 41 and 1991.
  • Another object of the invention is a protease described above, which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • a protease described above which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • all stabilization options described in the prior art and / or appropriate considerations come into consideration. Preference is given to those stabilizations which are achieved via mutations of the enzyme itself, since such stabilizations do not require any further working steps following the recovery of the enzyme. Examples of sequence changes suitable for this purpose are mentioned above. Other suitable sequence changes are known from the prior art.
  • proteases can also be stabilized by replacing one or more tyrosine residues with other amino acids.
  • amino acid (s) involved in the calcium binding with one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the sequences of the two amino acids arginine / glycine;
  • Preferred embodiments are those in which the enzyme is stabilized in several ways, as several stabilizing mutations act additive or synergistic.
  • Another object of the invention is a protease as described above, which is characterized in that it has at least one chemical modification.
  • a protease with such a change is called a derivative, i. the protease is derivatized.
  • derivatives are understood as meaning those proteins whose pure amino acid chain has been chemically modified.
  • Derivatizations can be made, for example, in vivo by the host cell expressing the protein. In this regard, couplings of low molecular weight compounds such as lipids or oligosaccharides are particularly noteworthy. However, derivatizations can also be carried out in vitro, for example by the chemical transformation of a side chain of an amino acid or by covalent binding of another compound to the protein. For example, the coupling of amines to carboxyl groups of an enzyme to alter the isoelectric point is possible. Such another compound may also be another protein that is bound to a protein of the invention via bifunctional chemical compounds, for example. Similarly, derivatization is the covalent bond to a
  • Derivatizations may, for example, affect the substrate specificity or binding strength to the substrate or cause a temporary blockage of the enzymatic activity when the coupled substance is an inhibitor. This can be useful, for example, for the period of storage. Such modifications may further affect stability or enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, increase its skin compatibility. For example, couplings with macromolecular compounds, for example, polyethylene glycol, can improve the protein in terms of stability and / or skin tolerance.
  • a protein may be associated with various other substances, for example from the culture of the producing microorganisms.
  • a protein may also have been deliberately added to other substances, for example to increase its storage stability.
  • proteases or protease variants and / or derivatives described above particular preference is given in the context of the present invention to those whose stability and / or activity is at least equal to that of the protease according to any one of SEQ ID NOs: 1-15 and / or their purification performance at least equal to that the protease according to any one of SEQ ID NOs. 1 -15 corresponds.
  • Another object of the invention is a nucleic acid encoding a protease of the invention, and a vector containing such a nucleic acid, in particular a
  • Cloning vector or an expression vector are provided.
  • DNA or RNA molecules may be DNA or RNA molecules. They can be present as a single strand, as a single strand that is complementary to this single strand, or as a double strand. Especially in the case of DNA molecules, the sequences of both complementary strands must be taken into account in all three possible reading frames. Furthermore, it should be noted that different codons, so base triplets, can code for the same amino acids, so that a particular amino acid sequence can be encoded by several different nucleic acids. Due to this degeneracy of the genetic code, all nucleic acid sequences are included in this subject of the invention which can encode any of the proteases described above.
  • nucleic acid sequences unequivocally since, despite the degeneracy of the genetic code, individual codons are assigned defined amino acids. Therefore, the person skilled in the art can easily determine nucleic acids coding for this amino acid sequence on the basis of an amino acid sequence.
  • one or more codons may be replaced by synonymous codons.
  • This aspect relates in particular to the heterologous expression of the enzymes according to the invention.
  • each organism for example a host cell of a production strain, has a particular codon usage. Codon usage is understood to mean the translation of the genetic code into amino acids by the particular organism.
  • Bottlenecks in protein biosynthesis can occur if the codons lying on the nucleic acid in the organism face a comparatively small number of loaded tRNA molecules. Although coding for the same amino acid, this results in a codon being translated less efficiently in the organism than a synonymous codon encoding the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, it can be more efficiently translated in the organism.
  • a person skilled in the art can use well-known methods such as chemical synthesis or the polymerase chain reaction (PCR) in combination with molecular biological and / or proteinchemical standard methods, using known DNA and / or amino acid sequences, the corresponding nucleic acids to complete genes manufacture. Such methods are known, for example, from Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
  • vectors are understood as consisting of nucleic acids which contain a nucleic acid according to the invention as a characteristic nucleic acid region. They can establish these in a species or cell line over several generations or cell divisions as a stable genetic element.
  • Vectors especially when used in bacteria, are special plasmids, ie circular genetic elements.
  • a nucleic acid according to the invention is cloned into a vector.
  • the vectors include, for example, those whose origin are bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of various origins. With the other genetic elements present in each case, vectors are able to establish themselves as stable units in the relevant host cells over several generations. They may be extra chromosomally present as separate units or integrated into a chromosome or chromosomal DNA.
  • Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to express a contained nucleic acid there.
  • expression is influenced by the promoter (s) that regulate transcription.
  • the expression may be effected by the natural promoter originally located in front of the nucleic acid to be expressed, but also by a promoter of the host cell provided on the expression vector or also by a modified or completely different promoter of another organism or another host cell.
  • at least one promoter for the expression of a nucleic acid according to the invention is made available and used for its expression.
  • expression vectors can be regulatable, for example by changing the culturing conditions or when a specific cell density of the host cells contained therein is reached or by addition of specific substances, in particular activators of gene expression.
  • An example of such a substance is the galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
  • IPTG galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside
  • lac operon lac operon
  • a further subject of the invention is a non-human host cell which contains a nucleic acid according to the invention or a vector according to the invention or which contains a protease according to the invention, in particular one which secretes the protease into the medium surrounding the host cell.
  • a nucleic acid according to the invention or a vector according to the invention is transformed into a microorganism, which then represents a host cell according to the invention.
  • individual components, ie nucleic acid parts or fragments of a nucleic acid according to the invention can be introduced into a host cell such that the resulting host cell contains a nucleic acid according to the invention or a vector according to the invention.
  • This procedure is particularly suitable when the host cell already contains one or more constituents of a nucleic acid according to the invention or a vector according to the invention and the further constituents are then supplemented accordingly.
  • Methods of transforming cells are well established in the art and well known to those skilled in the art. In principle, all cells, that is to say prokaryotic or eukaryotic cells, are suitable as host cells. Preference is given to those host cells which can be handled genetically advantageously, for example as regards the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria. Furthermore, preferred host cells are characterized by a good microbiological and
  • Preferred host cells according to the invention secrete the (transgenially) expressed protein into the medium surrounding the host cells.
  • the proteases can be modified by the cells producing them after their production, for example by attachment of sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the protease.
  • inventions are those host cells which are regulatable in their activity due to genetic regulatory elements which are provided, for example, on the vector, but may also be present in these cells from the outset.
  • Preferred host cells are prokaryotic or bacterial cells. Bacteria are characterized by short generation times and low demands on cultivation conditions. As a result, inexpensive cultivation methods or production methods can be established. moreover the expert has a rich in bacteria in fermentation technology
  • gram-negative or gram-positive bacteria may be suitable for a wide variety of reasons to be determined experimentally in individual cases, such as nutrient sources, product formation rate, time requirement, etc.
  • Gram-negative bacteria such as Escherichia coli
  • Gram-negative bacteria can also be designed such that they eject the expressed proteins not only into the periplasmic space but into the medium surrounding the bacterium.
  • Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of Actinomycetales have no outer membrane, so that secreted proteins readily into the medium surrounding the bacteria, usually the
  • Nutrient medium can be dispensed, from which the expressed proteins can be purified. They can be isolated directly from the medium or further processed.
  • Gram-positive bacteria are related or identical to most of the organisms of origin for technically important enzymes and usually form even comparable enzymes, so they have a similar codon use and their protein synthesizer is naturally aligned accordingly.
  • Host cells according to the invention may be altered in their requirements of the culture conditions, have different or additional selection markers or express other or additional proteins. In particular, it may also be those host cells which express several proteins or enzymes transgene.
  • the present invention is applicable in principle to all microorganisms, in particular to all fermentable microorganisms, particularly preferably those of the genus Bacillus, and results in the production of proteins according to the invention by the use of such microorganisms. Such microorganisms then represent host cells in the sense of the invention.
  • the host cell is characterized in that it is a bacterium, preferably one selected from the genera of Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one selected from the group consisting of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and
  • the host cell may also be a eukaryotic cell, which is characterized in that it has a cell nucleus.
  • a further subject of the invention therefore represents a host cell, which is characterized in that it has a cell nucleus.
  • eukaryotic cells are capable of producing the protein formed
  • fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces.
  • yeasts such as Saccharomyces or Kluyveromyces.
  • Modifications that eukaryotic systems perform, especially in connection with protein synthesis include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides.
  • oligosaccharide modifications may be desirable, for example, to lower the allergenicity of an expressed protein.
  • coexpression with the enzymes naturally produced by such cells, such as cellulases or lipases may be advantageous.
  • thermophilic fungal expression systems may be particularly suitable for the expression of temperature-resistant proteins or variants.
  • the host cells according to the invention are conventionally cultivated and fermented, for example in discontinuous or continuous systems.
  • a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after an experimentally determined period of time.
  • Continuous fermentations are characterized by achieving a flow equilibrium, in which over a relatively long period of time cells partly die out but also regrow and at the same time the protein formed can be removed from the medium.
  • Host cells according to the invention are preferably used to produce proteases according to the invention.
  • Another object of the invention is therefore a method for preparing a protease comprising
  • This subject invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, usually followed by a suitable purification method of the product produced, for example the protease according to the invention. All fermentation Methods based on a corresponding method for producing a protease according to the invention, embodiments of this subject invention represent.
  • Fermentation processes which are characterized in that the fermentation is carried out via a feed strategy, come in particular into consideration.
  • the fermentation is carried out via a feed strategy
  • the fermentation can also be designed so that undesired metabolic products are filtered out or neutralized by the addition of buffer or suitable counterions.
  • the protease produced can be harvested from the fermentation medium. Such a fermentation process is resistant to isolation of the protease from the host cell, i. a product preparation from the cell mass (dry matter) preferred, but requires the
  • suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems for the host cells to secrete the protease into the fermentation medium.
  • the isolation of the protease from the host cell i. a purification of the same from the cell mass, carried out, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
  • Another object of the invention is an agent which is characterized in that it contains a protease according to the invention as described above.
  • the agent is preferably a washing or cleaning agent.
  • This subject matter of the invention includes all conceivable types of detergents or cleaners, both concentrates and undiluted agents, for use on a commercial scale, in the washing machine or in hand washing or cleaning. These include detergents for textiles, carpets, or natural fibers for which the
  • Label detergent is used. These include, for example, dishwashing detergents for dishwashers or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term detergent is used, ie in addition to manual and machine Dishwashing, for example, scouring agents, glass cleaner, toilet scent, etc.
  • the washing and cleaning agents in the context of the invention also include washing aids, which are metered into the actual detergent in manual or automatic textile washing in order to achieve a further effect. Furthermore count to washing and
  • Textilvor- and post-treatment agent ie those means with which the garment is brought into contact before the actual laundry, for example, to dissolve stubborn dirt, and also such agents, the laundry downstream in one of the actual textile laundry further give desirable properties such as comfortable grip, crease resistance or low static charge.
  • the fabric softener i.a. calculated the fabric softener.
  • washing or cleaning agents according to the invention which may be in the form of homogeneous solutions or suspensions in the form of powdered solids, may contain, in addition to a protease according to the invention, all known ingredients customary in such agents, preferably at least one further ingredient being present in the composition ,
  • the agents according to the invention may in particular be surfactants, builders,
  • peroxygen compounds or bleach activators may contain water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, grayness inhibitors, foam regulators, as well as dyes and fragrances, and combinations thereof.
  • water-miscible organic solvents such as water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, grayness inhibitors, foam regulators, as well as dyes and fragrances, and combinations thereof.
  • these agents contain an inhibitor for the proteases according to the invention, preferably benzylmalonic acid.
  • Benzylmalonic acid can be used in an amount of 1 g / L to 100 g / L, preferably 5 g / L - 50 g / L, in each case based on the volume of the (liquid) washing or cleaning agent.
  • Boric acid is also contained in specific embodiments of the invention in an amount of 1 g / L to 100 g / L, preferably 5 g / L - 50 g / L, in each case based on the volume of the (liquid) detergent or cleaner.
  • a combination of a protease of the invention with one or more other ingredients of the composition is advantageous because such agent, in preferred embodiments of the invention, has improved cleaning performance by resulting synergisms.
  • a protease according to the invention with a surfactant and / or a builder (builder) and / or a peroxygen compound and / or a bleach activator, such a synergism can be achieved.
  • Patent application WO2009 / 121725 starting there on page 5, penultimate paragraph, and ending on Page 13 after the second paragraph. This disclosure is incorporated herein by reference and the disclosure is incorporated herein by reference.
  • An agent according to the invention advantageously contains the protease in an amount of from 2 ⁇ g to 20 mg, preferably from 5 ⁇ g to 17.5 mg, more preferably from 2 ⁇ g to 15 mg and very particularly preferably from 5 ⁇ g to 10 mg per g of the composition.
  • the protease contained in the agent, and / or other ingredients of the agent may be coated with a substance impermeable to the enzyme at room temperature or in the absence of water, which becomes permeable to the enzyme under conditions of use of the agent.
  • Such an embodiment of the invention is thus characterized in that the protease with a at
  • washing or cleaning agent itself may be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.
  • the agent is characterized in that it
  • (A) is in solid form, in particular as a free-flowing powder having a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or
  • (b) is in pasty or liquid form, and / or
  • (c) is present as a one-component system, or
  • compositions according to the invention include all solid, powdered, liquid, gelatinous or paste-like administration forms of compositions according to the invention, which if appropriate can also consist of several phases and can be present in compressed or uncompressed form.
  • the agent can be present as a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l.
  • the solid dosage forms of the composition also include extrudates, granules, tablets or pouches.
  • the agent can also be liquid, gelatinous or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste.
  • agent may be present as a one-component system. Such funds consist of one phase. Alternatively, an agent can also consist of several phases. Such an agent is therefore divided into several components.
  • Detergents or cleaning agents according to the invention may contain only one protease. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration effective for the effectiveness of the agent. Another embodiment The invention thus provides agents which further comprise one or more further enzymes. Preferred enzymes which can be used as further enzymes are all enzymes which can develop a catalytic activity in the agent according to the invention, in particular a protease, amylase, cellulase,
  • Other enzymes are incorporated in the means advantageously each in an amount of 1 x 10 "-8 to 5 weight percent based on active protein.
  • Each additional enzyme is increasingly preferred in an amount of 1 x 10 -3 7 wt .-%, of 0.00001-1% by weight, from 0.00005-0.5% by weight, from 0.0001 to 0.1% by weight, and more preferably from 0.0001 to 0.05% by weight
  • the enzymes particularly preferably show synergistic cleaning performances with respect to certain stains or stains, ie the enzymes contained in the middle composition mutually support each other in their cleaning performance, very particularly preferably such synergism exists between the protease according to the invention and a further enzyme of a composition according to the invention, in particular between said protease and the amylase and / or a lipase and / or a mannanase and / or a cellulase and / or a Pe ktinase.
  • Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the composition according to the invention.
  • a further subject of the invention is a process for the purification of textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one process step, or in at least one process step, a protease of the invention becomes catalytically active, in particular such that the protease in an amount of 40 ⁇ g to 4g, preferably from 50 ⁇ g to 3g, more preferably from 100 ⁇ g to 2g and most preferably from 200 ⁇ g to 1g is used.
  • Processes for the purification of textiles are generally distinguished by the fact that various cleaning-active substances are applied to the fabric in several process steps
  • the material to be cleaned is applied and washed off after the action time, or the material to be cleaned is treated in any other way with a detergent or a solution or dilution of this agent.
  • a detergent or a solution or dilution of this agent can be enriched in at least one of the method steps to the application of a detergent or protease according to the invention and then represent embodiments of the present invention.
  • All facts, objects and embodiments which are proteases of the invention and they containing agents are described, are also applicable to this subject of the invention. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also for the above inventive
  • proteases according to the invention naturally already have a hydrolytic activity and also unfold them in media which otherwise have no cleaning power, for example in bare buffer, a single and / or the sole step of such a method may be that, if desired, the only cleaning-active component is an inventive Protease is brought into contact with the soiling, preferably in a buffer solution or in water. This represents a further embodiment of this subject of the invention.
  • a protease of the invention is active.
  • methods for textile raw materials, fibers or textiles with natural components are preferred, and especially for those with wool or silk.
  • Another subject of the invention is the use of an agent according to the invention for cleaning textiles or hard surfaces, or a protease according to the invention for the purification of textiles or hard surfaces, in particular such that the protease in an amount of 4C ⁇ g to 4g, preferably 5C ⁇ g to 3g, more preferably from 10C ⁇ g to 2g, and most preferably from 20C ⁇ g to 1g is used.
  • Example 1 Stability of the Starting Molecule - Variant A.
  • protease variant adapted to the inhibitor BMA with a sequence according to SEQ ID NO.1 was compared to established proteases, such as the protease with a sequence according to SEQ ID NO.17 (B) and the protease, which has a with the sequence according to the variant F49 from W09523221 identical amino acid sequence (C), in a test at 60 ° C / pH 10 on temperature stability and at 40 ° C / pH8 and presence of Texapon or linear
  • Alkylbenzenesulfonate used. At regular intervals, the activity was determined by AAPF test. The half-life was calculated assuming a pseudo-1. Order after
  • a protease variant according to the invention was prepared by site-directed mutagenesis in the nucleic acid coding for the protease by means of the "PHUSION site-directed mutagenesis kit" (Finnzyme, F541).
  • Amino acid sequence was a substitution of the amino acids as indicated.
  • the expression of the protease variant was carried out in a customary manner by transformation of Bacillus subtilis DB 104 (Kawamura and Doi (1984), J. Bacteriol., Vol. 160 (1), p. 442-444) with a corresponding expression vector and subsequent culture of the protease variant expressing transformants.
  • the proteases were purified by ion exchange chromatography from the appropriate cultures.
  • Example 3 Stability Tests at High Temperatures in the Presence of a Detergent Matrix The variants fermented in parallel in screening tests were added in the same concentration as fermentation supernatant from minimized culture to a product-near detergent matrix and incubated at 50 or 55 ° C. At regular intervals the activity was determined by AAPF test. The half-life was calculated assuming a pseudo-1. Order determined after linearization.
  • Variant D 144 It is clear that the reduced half-life of the variants in the presence of surfactants compared to protease (B) is restored by the introduced mutations and even increased by synergistic use.
  • the supernatant of the proteases obtained according to Example 2 was dialyzed against a 5 mM HEPES buffer system at pH 7.8 for high isoelectric point protons and oh 7.2 with low isoelectric point.
  • the purification was then carried out in the appropriate, 50 mM HEPES buffer via an anion and a cation exchanger and subsequent elution of the cation exchanger by a NaCl gradient.
  • the isolated protease fractions were pooled, stabilized by 20% PG and stored at 4 ° C.
  • inhibitor benzylmalonic acid
  • protease variant D can be better inhibited similar to the starting molecule protease variant A than the protease variant B.
  • Example 6 Storage tests in detergent matrices
  • protease purified protease variants A, B and D were added in equal concentrations to detergent matrix formulations with 1% BMA.
  • the batches were stored at 30 ° C and the Protease activity determined regularly. This resulted in the following half-lives (determined by linearization assuming pseudo-1. Order:
  • protease variant D in contrast to variant A, has a markedly improved storage stability and also shows higher stabilities compared to protease variant B.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des protéases comprenant une séquence d'acides aminés qui présente sur toute sa longueur une identité de séquence d'au moins 70% par rapport à la séquence d'acides aminés indiquée dans la SEQ ID N° 1, qui contient les résidus acides aminés 160G et 185R et dans laquelle les acides aminés sont remplacés par 39E, 74D, 253D, 3T, 4I et 199I dans au moins une, de préférence 2, de préférence 3, en particulier 4, de façon particulièrement préférée 5 et de façon tout particulièrement préférée 6 des positions correspondant aux positions 39, 74, 253 ainsi que 3, 4, 199 de la SEQ ID N° 1. L'invention concerne en outre leur préparation et leur utilisation. Ces protéases possèdent une très bonne stabilité, en particulier aux surfactants, en même temps que de bonnes performances d'inhibition, en particulier avec l'acide benzylmalonique.
PCT/EP2014/070377 2013-09-26 2014-09-24 Variantes de protéases inhibitrices stabilisées WO2015044206A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14772337.3A EP3049519A1 (fr) 2013-09-26 2014-09-24 Variantes de protéases inhibitrices stabilisées

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013219467.6 2013-09-26
DE201310219467 DE102013219467A1 (de) 2013-09-26 2013-09-26 Stabilisierte Inhibitor-Proteasevarianten

Publications (1)

Publication Number Publication Date
WO2015044206A1 true WO2015044206A1 (fr) 2015-04-02

Family

ID=51619175

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/070377 WO2015044206A1 (fr) 2013-09-26 2014-09-24 Variantes de protéases inhibitrices stabilisées

Country Status (3)

Country Link
EP (1) EP3049519A1 (fr)
DE (1) DE102013219467A1 (fr)
WO (1) WO2015044206A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3660151A1 (fr) * 2018-11-29 2020-06-03 Henkel AG & Co. KGaA Variantes de prothèse stables au stockage et à la performance améliorée
US10731111B2 (en) 2015-11-25 2020-08-04 Conopco, Inc. Liquid laundry detergent composition
US10913919B2 (en) 2018-06-19 2021-02-09 The Procter & Gamble Company Automatic dishwashing detergent composition
WO2021239818A1 (fr) * 2020-05-26 2021-12-02 Novozymes A/S Variants de subtilase et compositions les comprenant
US11220656B2 (en) 2018-06-19 2022-01-11 The Procter & Gamble Company Automatic dishwashing detergent composition
US11746341B2 (en) 2018-11-29 2023-09-05 Henkel Ag & Co. Kgaa Performance-enhanced and storage stable protease variants
WO2023232193A1 (fr) * 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Détergents et produits de nettoyage à stabilité enzymatique améliorée
WO2023232194A1 (fr) * 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Détergents et agents de nettoyage à stabilité enzymatique améliorée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011032988A1 (fr) * 2009-09-16 2011-03-24 Henkel Ag & Co. Kgaa Lessive ou détergent liquide stable au stockage contenant des protéases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056187C (zh) * 1988-02-11 2000-09-06 金克克国际有限公司 新的蛋白水解酶及其在洗涤剂中的应用
US5340735A (en) 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
DE69535736T2 (de) 1994-02-24 2009-04-30 Henkel Ag & Co. Kgaa Verbesserte enzyme und diese enthaltene detergentien
DE19530816A1 (de) * 1995-08-23 1997-02-27 Cognis Bio Umwelt Verwendung von mutierter Subtilisin-Protease in kosmetischen Produkten
MA25044A1 (fr) * 1997-10-23 2000-10-01 Procter & Gamble Compositions de lavage contenant des variants de proteases multisubstituees.
DE10121463A1 (de) * 2001-05-02 2003-02-27 Henkel Kgaa Neue Alkalische Protease-Varianten und Wasch- und Reinigungsmittel enthaltend diese neuen Alkalischen Protease-Varianten
DE102008017103A1 (de) 2008-04-02 2009-10-08 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel enthaltend Proteasen aus Xanthomonas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011032988A1 (fr) * 2009-09-16 2011-03-24 Henkel Ag & Co. Kgaa Lessive ou détergent liquide stable au stockage contenant des protéases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FELIX JACOB: "Engineering of subtilisin proteases for detergent applications", 8 May 2013 (2013-05-08), XP002732268, Retrieved from the Internet <URL:http://darwin.bth.rwth-aachen.de/opus3/volltext/2013/4772> *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10731111B2 (en) 2015-11-25 2020-08-04 Conopco, Inc. Liquid laundry detergent composition
US10913919B2 (en) 2018-06-19 2021-02-09 The Procter & Gamble Company Automatic dishwashing detergent composition
US11220656B2 (en) 2018-06-19 2022-01-11 The Procter & Gamble Company Automatic dishwashing detergent composition
EP3660151A1 (fr) * 2018-11-29 2020-06-03 Henkel AG & Co. KGaA Variantes de prothèse stables au stockage et à la performance améliorée
US11359189B2 (en) 2018-11-29 2022-06-14 Henkel Ag & Co. Kgaa Performance-enhanced and storage stable protease variants
US11746341B2 (en) 2018-11-29 2023-09-05 Henkel Ag & Co. Kgaa Performance-enhanced and storage stable protease variants
EP3660146B1 (fr) 2018-11-29 2023-11-15 Henkel AG & Co. KGaA Variantes de prothèse stables au stockage et à la performance améliorée
EP4253511A3 (fr) * 2018-11-29 2023-12-06 Henkel AG & Co. KGaA Variants de protéases présentant une performance ameliorée et stabilité au stockage
WO2021239818A1 (fr) * 2020-05-26 2021-12-02 Novozymes A/S Variants de subtilase et compositions les comprenant
WO2023232193A1 (fr) * 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Détergents et produits de nettoyage à stabilité enzymatique améliorée
WO2023232194A1 (fr) * 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Détergents et agents de nettoyage à stabilité enzymatique améliorée

Also Published As

Publication number Publication date
DE102013219467A9 (de) 2015-05-13
EP3049519A1 (fr) 2016-08-03
DE102013219467A1 (de) 2015-03-26

Similar Documents

Publication Publication Date Title
EP2771459B1 (fr) Variants des proteases avec des performances ameliorees et insensibles a temperature
EP2545169B1 (fr) Proteases avec des efficiences ameliorées
EP3679133A1 (fr) Variantes de protéases à performances améliorées
WO2015044206A1 (fr) Variantes de protéases inhibitrices stabilisées
EP3679131A1 (fr) Variantes de protéases à performances améliorées
EP3679132B1 (fr) Variantes de protéase à performances améliorées
EP3058057A1 (fr) Variants de protéase à stabilité accrue
EP3433360B1 (fr) Protéases présentant une meilleure stabilité enzymatique dans les détergents
EP2683808B1 (fr) Variantes de protéase à performance améliorée
EP3433359B1 (fr) Performance de nettoyage améliorée sur des salissures sensibles aux protéines
EP3458583A1 (fr) Protéases à performance améliorée
DE102017215628A1 (de) Leistungsverbesserte Proteasevarianten I
EP3440203B1 (fr) Nouvelle protéase à performance de lavage améliorée
DE102012220101A1 (de) Leistungsverbesserte Proteasevarianten
DE102018208777A1 (de) Leistungsverbesserte Proteasevarianten V
DE102017215631A1 (de) Leistungsverbesserte Proteasevarianten II
WO2012000829A1 (fr) Nouvelles protéases et agents les contenant
WO2015091089A1 (fr) Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14772337

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2014772337

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014772337

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE